Hillstar Bio
PrivateLast Round
Series A
Mar 25, 2025
Total Funding Raised
$67M
Company Overview
Hillstar Bio operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in March 2025.
Hillstar Bio is a biotechnology company that develops next-generation precision immunology therapies for autoimmune diseases by selectively targeting and depleting pathogenic immune cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hillstar Bio Comparables
Compare Hillstar Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 82% | |
| Seismic | 74% | |
| AbbVie | 68% |
For institutional investors. Book with your work email.
Hillstar Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hillstar Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Series A |
| Frazier Life Sciences | Series A |
| Novo Holdings | Series A |
| LifeArc Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2025
Grew 28% QoQ, from 18 to 23 employees.
- Jun 3, 2025
Grew 64% QoQ, from 11 to 18 employees.
For institutional investors. Book with your work email.
Hillstar Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hillstar Bio's valuation, stock price, and market status.
Is Hillstar Bio a public or private company?
Hillstar Bio is a private company.
What is the current stock price of Hillstar Bio?
Hillstar Bio is a private company, so its shares have no public market price. Caplight tracks Hillstar Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hillstar Bio worth (valuation)?
Valuation information for Hillstar Bio is not publicly available.
Can I buy Hillstar Bio stock?
Hillstar Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hillstar Bio's last funding round?
Hillstar Bio's most recent funding round was Series A on March 25, 2025.
Who are the main investors in Hillstar Bio?
Key investors in Hillstar Bio include Droia Ventures, Frazier Life Sciences, Novo Holdings.
Will Hillstar Bio IPO soon?
No public IPO plans have been announced for Hillstar Bio.
How can I track Hillstar Bio secondary market activity?
Caplight tracks bids, offers, and trades in Hillstar Bio's shares on secondary markets.